Actively Recruiting

Age: 18Years +
All Genders
NCT05508932

Atrial Fibrillation in Beta-Thalassemia

Led by University Hospital of Ferrara · Updated on 2026-02-24

350

Participants Needed

1

Research Sites

513 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The study aims to evaluate the clinical, laboratory and instrumental differences that exist between beta-thalassemia patients with atrial fibrillation and those not affected by arrhythmia.

CONDITIONS

Official Title

Atrial Fibrillation in Beta-Thalassemia

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Transfusion-dependent Beta-thalassemia
  • Follow-up at the Cardiology Unit of the University Hospital of Ferrara
  • Electrocardiogram performed
  • Echocardiogram performed
Not Eligible

You will not qualify if you...

  • Younger than 18 years
  • Currently pregnant
  • Unable to give informed consent

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Matteo Bertini

Ferrara, Italy

Actively Recruiting

Loading map...

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here